sarin has been researched along with adenosine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bueters, TJ; Danhof, M; Groen, B; IJzerman, AP; Van Helden, HP | 1 |
| Bueters, TJ; Danhof, M; Ijzerman, AP; Joosen, MJ; van Helden, HP | 1 |
| Bueters, TJ; Harrison, PK; Ijzerman, AP; Tattersall, JE; van Helden, HP | 1 |
| Bueters, TJ; Joosen, MJ; van Helden, HP | 1 |
| Beste, A; Shih, TM; Taylor, DE; Thomas, TP | 1 |
| Acon-Chen, C; Loughery, TN; Shih, TM; Whitten, KA | 1 |
6 other study(ies) available for sarin and adenosine
| Article | Year |
|---|---|
Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication.
Topics: Acetylcholine; Adenosine; Animals; Cholinesterase Inhibitors; Cholinesterases; Corpus Striatum; Male; Microdialysis; Organophosphate Poisoning; Organophosphates; Organothiophosphorus Compounds; Parathion; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Sarin | 2002 |
Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin.
Topics: Acetylcholinesterase; Adenosine; Animals; Blood; Brain; Cholinesterase Inhibitors; Drug Interactions; Male; Models, Biological; Rats; Rats, Wistar; Receptors, Purinergic P1; Sarin; Tissue Distribution | 2003 |
Partial adenosine A(1) receptor agonists inhibit sarin-induced epileptiform activity in the hippocampal slice.
Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Deoxyadenosines; Guinea Pigs; Hippocampus; Male; Microelectrodes; Neurons; Receptor, Adenosine A1; Sarin; Seizures; Soman; Structure-Activity Relationship; Xanthines | 2003 |
Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning.
Topics: Adenosine; Animals; Bradycardia; Chemical Warfare Agents; Dose-Response Relationship, Drug; Drug Antagonism; Drug Therapy, Combination; Heart Diseases; Hypotension; Injections, Intramuscular; Male; Poisoning; Purinergic P1 Receptor Agonists; Rats; Sarin; Theophylline | 2004 |
Mechanisms of acetylcholinesterase protection against sarin and soman by adenosine A
Topics: Acetylcholinesterase; Adenosine; Adenosine A1 Receptor Agonists; Animals; Molecular Structure; Nerve Agents; Organophosphorus Compounds; Quantum Theory; Rats; Sarin; Soman; Thermodynamics | 2018 |
Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anticonvulsants; Brain; Deoxyadenosines; Disease Models, Animal; Drug Administration Schedule; Injections, Intramuscular; Male; Neuroprotective Agents; Norbornanes; Rats, Sprague-Dawley; Sarin; Soman; Status Epilepticus; Time Factors | 2021 |